Ripple Therapeutics

Ripple Therapeutics is a privately held, clinical-stage company focused on ophthalmic therapies with controlled, sustained drug delivery. Ripple's core functional technology, Epidal, enables the design of extended-release drugs with surface erosion release kinetics without the use of polymers or excipients. Ripple's innovative therapies offer improved outcomes for patients, easier care management for physicians, and lower costs for payers.